{"id":4559,"date":"2025-09-25T12:50:25","date_gmt":"2025-09-25T09:50:25","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4559"},"modified":"2025-11-03T20:20:40","modified_gmt":"2025-11-03T17:20:40","slug":"mutations-and-deletions-amenable-to-exon-53-skipping-therapies-dmd","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/tr\/mutations-and-deletions-amenable-to-exon-53-skipping-therapies-dmd\/","title":{"rendered":"Duchenne Musk\u00fcler Distrofisi \u0130\u00e7in Ekzon 53 Atlamaya Uygun Delesyonlar ve Mutasyonlar"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Duchenne Kas Distrofisi (DMD), \u00f6ncelikle erkek \u00e7ocuklar\u0131n\u0131 etkileyen, distrofin genindeki mutasyonlar nedeniyle kas g\u00fc\u00e7s\u00fczl\u00fc\u011f\u00fc ve dejenerasyonuna neden olan, g\u00fc\u00e7ten d\u00fc\u015f\u00fcren ve ilerleyici bir genetik hastal\u0131kt\u0131r. Y\u0131llar i\u00e7inde, DMD&#039;nin ilerlemesini durdurmak i\u00e7in tedavi y\u00f6ntemleri geli\u015ftirilmi\u015f olup, en umut verici olanlardan biri ekzon atlama tedavileridir. Bu tedaviler, distrofin genindeki hatal\u0131 ekzonlar\u0131 atlayarak, genetik mutasyonlar olsa bile fonksiyonel bir distrofin proteininin \u00fcretilmesini sa\u011flamay\u0131 ama\u00e7lar. Ekzon 53 atlama, DMD tedavisinde \u00f6nemli ilgi g\u00f6ren bu t\u00fcr hedefli tedavilerden biridir. <strong>Bu makalede, distrofin genindeki hangi mutasyon ve delesyonlar\u0131n ekzon 53 atlama tedavilerine uygun oldu\u011funu ve bu yakla\u015f\u0131m\u0131n etkilenen hastalar i\u00e7in nas\u0131l umut sundu\u011funu inceleyece\u011fiz.<\/strong> - Daha fazla bilgi edin: <a href=\"https:\/\/dmdwarrior.com\/tr\/what-is-duchenne\/\" target=\"_blank\" data-type=\"post\" data-id=\"588\" rel=\"noreferrer noopener\">Duchenne Nedir?<\/a> \u2013<\/p>\n\n\n\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>\u0130\u00e7indekiler<\/h2><nav><ul><li><a href=\"#exon-skipping-a-breakthrough-approach-for-dmd\">Ekzon Atlama: DMD \u0130\u00e7in \u00c7\u0131\u011f\u0131r A\u00e7an Bir Yakla\u015f\u0131m<\/a><\/li><li><a href=\"#how-exon-53-skipping-works-for-dmd\">Ekzon 53 Atlama DMD'de Nas\u0131l \u00c7al\u0131\u015f\u0131r?<\/a><\/li><li><a href=\"#mutations-and-deletions-amenable-to-exon-53-skipping\">Ekzon 53 Atlamaya Uygun Delesyonlar<\/a><\/li><li><a href=\"#common-deletions-amenable-to-exon-53-skipping\">Ekzon 53 Atlamaya Uygun Yayg\u0131n G\u00f6r\u00fclen Delesyonlar<\/a><\/li><li><a href=\"#mutations-amenable-to-exon-51-skipping\">Ekzon 53 Atlamaya Uygun Mutasyonlar<\/a><ul><li><a href=\"#golodirsen-a-leading-exon-53-skipping-drug\">Golodirsen: \u00d6nde Gelen Bir Ekzon 53 Atlama Tedavisi<\/a><ul><li><a href=\"#clinical-trials-and-results\">Klinik Ara\u015ft\u0131rmalar ve Sonu\u00e7lar\u0131<\/a><\/li><\/ul><\/li><li><a href=\"#benefits-of-exon-53-skipping-therapy-for-dmd-patients\">DMD Hastalar\u0131 \u0130\u00e7in Ekzon 53 Atlama Terapisinin Faydalar\u0131<\/a><\/li><li><a href=\"#future-prospects-expanding-exon-skipping-therapies\">Gelecek Beklentileri: Ekzon Atlama Terapilerinin Geni\u015fletilmesi<\/a><\/li><\/ul><\/li><li><a href=\"#summary-is-your-child-a-candidate-for-exon-51-skipping\">\u00d6zet: O\u011flum Ekzon 53 Atlamaya Uygun mu?<\/a><ul><li><a href=\"#conclusion\">Sonu\u00e7<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"exon-skipping-a-breakthrough-approach-for-dmd\"><strong>Ekzon Atlama: DMD \u0130\u00e7in \u00c7\u0131\u011f\u0131r A\u00e7an Bir Yakla\u015f\u0131m<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ekzon atlama, RNA ekleme i\u015flemi s\u0131ras\u0131nda distrofin geninin kusurlu k\u0131s\u0131mlar\u0131n\u0131n (ekzonlar\u0131n) &quot;atlanmas\u0131n\u0131&quot; ama\u00e7layan bir gen tedavisi bi\u00e7imidir. Ama\u00e7, genin okuma \u00e7er\u00e7evesini eski haline getirmek ve distrofin proteininin k\u0131salt\u0131lm\u0131\u015f ancak i\u015flevsel bir versiyonunun \u00fcretilmesini sa\u011flamakt\u0131r. Bu yakla\u015f\u0131m, \u00f6zellikle distrofin geninde, genellikle i\u015flevsel olmayan bir distrofin proteini \u00fcreten okuma \u00e7er\u00e7evesinin bozulmas\u0131na neden olan belirli delesyonlar\u0131 olan hastalar i\u00e7in faydal\u0131d\u0131r. \u2013 Devam\u0131n\u0131 Oku: <a href=\"https:\/\/dmdwarrior.com\/tr\/what-is-exon-skipping-and-how-does-it-work\/\" target=\"_blank\" data-type=\"post\" data-id=\"1445\" rel=\"noreferrer noopener\">Ekzon atlama nedir?<\/a> \u2013<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ekzon 53 gibi belirli ekzonlar\u0131n atlanmas\u0131yla tedavi, do\u011fru okuma \u00e7er\u00e7evesini yeniden olu\u015fturarak kas h\u00fccresi stabilitesini ve i\u015flevini korumaya yard\u0131mc\u0131 olabilecek fonksiyonel bir distrofin proteininin \u00fcretilmesini sa\u011flar. Ekzon atlamas\u0131 DMD'yi iyile\u015ftirmez, ancak hastal\u0131\u011f\u0131n ilerlemesini yava\u015flatabilir ve hastalar\u0131n ya\u015fam kalitesini iyile\u015ftirebilir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"how-exon-53-skipping-works-for-dmd\"><strong>Ekzon 53 Atlama DMD'de Nas\u0131l \u00c7al\u0131\u015f\u0131r?<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ekzon 53 atlama, distrofin proteininin \u00fcretiminde \u00f6nemli olan distrofin geninin bir b\u00f6lgesini \u00f6zel olarak hedef al\u0131r. <strong>Ekzon 53 atlama, genin ekzon 53 veya \u00e7evresindeki b\u00f6lgelerini ilgilendiren delesyonlar\u0131 olan hastalar\u0131n bir alt grubuna hitap etti\u011fi i\u00e7in \u00f6nemli bir tedavi yakla\u015f\u0131m\u0131 haline gelmi\u015ftir.<\/strong> Bu mutasyonlar okuma \u00e7er\u00e7evesini bozarak distrofin proteininin i\u015flevsizle\u015fmesine veya yoklu\u011funa yol a\u00e7ar.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">RNA eklemesi s\u0131ras\u0131nda ekzon 53 atland\u0131\u011f\u0131nda, okuma \u00e7er\u00e7evesi geri y\u00fcklenir ve k\u0131salt\u0131lm\u0131\u015f ancak i\u015flevsel bir distrofin proteini \u00fcretilebilir. Bu k\u0131salt\u0131lm\u0131\u015f distrofin, tam uzunluktaki protein kadar b\u00fcy\u00fck veya verimli olmasa da, kas h\u00fccrelerini hasardan korumak i\u00e7in yeterli stabilite sa\u011flar. Distrofin \u00fcretiminin bu \u015fekilde yeniden sa\u011flanmas\u0131, hastal\u0131\u011f\u0131n ilerlemesini yava\u015flatabilir, kas g\u00fcc\u00fcn\u00fc art\u0131rabilir ve motor fonksiyon kayb\u0131n\u0131 geciktirebilir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"mutations-and-deletions-amenable-to-exon-53-skipping\"><strong>Ekzon 53 Atlamaya Uygun Delesyonlar<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ekzon 53 atlama, Duchenne Musk\u00fcler Distrofi hastalar\u0131n\u0131n bir alt grubu i\u00e7in, spesifik ekzonlar\u0131 i\u00e7eren delesyonlar\u0131 olanlar i\u00e7in hedefli bir tedavi stratejisini temsil eder<\/strong>: 3-52, 4-52, 5-52, 6-52, 9-52, 10-52, 11-52, 13-52, 14-52, 15-52, 16-52, 17-52, 19-52, 21-52, 23-52, 24-52, 25-52, 26-52 27-52, 28-52, 29-52, 30-52, 31-52, 32-52, 33-52, 34-52, 35-52, 36-52, 37-52, 38-52, 39-52, 40-52, 41-52, 42-52, 43-52, 45-52, 47-52, 48-52, 49-52, 50-52, 52, 54-58, 54-61, 54-63, 54-64, 54-66, 54-76, 54-77.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"847\" height=\"1024\" src=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR.jpg\" alt=\"Duchenne Musk\u00fcler Distrofisi \u0130\u00e7in Ekzon 53 Atlamaya Uygun Delesyonlar ve Mutasyonlar\" class=\"wp-image-4566\" title=\"\" srcset=\"https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR.jpg 1984w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-248x300.jpg 248w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-847x1024.jpg 847w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-768x929.jpg 768w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-1270x1536.jpg 1270w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-1693x2048.jpg 1693w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-10x12.jpg 10w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-347x420.jpg 347w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-150x181.jpg 150w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-300x363.jpg 300w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-696x842.jpg 696w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-1068x1292.jpg 1068w, https:\/\/dmdwarrior.com\/wp-content\/uploads\/2025\/11\/amenable-to-exon-53-skipping-TR-1920x2323.jpg 1920w\" sizes=\"auto, (max-width: 847px) 100vw, 847px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Ekzon 53 atlama aday\u0131 olabilmek i\u00e7in hastan\u0131n ekzon 53 atlanarak d\u00fczeltilebilen bir \u00e7er\u00e7eve kayd\u0131rma delesyonuna sahip olmas\u0131 gerekir. Ama\u00e7, DMD genini do\u011fru okuma \u00e7er\u00e7evesine geri getirmektir.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"common-deletions-amenable-to-exon-53-skipping\"><strong>Ekzon 53 Atlamaya Uygun Yayg\u0131n G\u00f6r\u00fclen Delesyonlar<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ekzon 53 atlamas\u0131, distrofin geninin okuma \u00e7er\u00e7evesini bozan spesifik genetik delesyonlar\u0131 olan DMD hastalar\u0131 i\u00e7in etkilidir. Bu tedaviye uygun en yayg\u0131n delesyonlar \u015funlard\u0131r:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ekzon 52 Delesyonu<\/strong>: 52. ekzonun do\u011frudan silinmesi, \u00e7er\u00e7eve kaymas\u0131 mutasyonuna yol a\u00e7arak i\u015flevsiz bir distrofin proteini \u00fcretir. Bu ekzonun atlanmas\u0131, genin okuma \u00e7er\u00e7evesini geri y\u00fckleyerek i\u015flevsel bir distrofin \u00fcretilmesine olanak tan\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>45 ila 52. Ekzonlar\u0131 Kapsayan Delesyonlar<\/strong>: 45&#039;ten 52&#039;ye kadar olan ekzonlar\u0131 etkileyen delesyonlar, 53&#039;\u00fcnc\u00fc ekzonun atlanmas\u0131yla da d\u00fczeltilebilir, b\u00f6ylece distrofin \u00fcretimi yeniden sa\u011flan\u0131r ve kas fonksiyonu stabilize edilir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>50 ila 52. Ekzonlar Aras\u0131ndaki Delesyonlar<\/strong>: Bu t\u00fcr bir delesyon, ekzon 53&#039;\u00fcn atlanmas\u0131yla onar\u0131labilen bir \u00e7er\u00e7eve kaymas\u0131na neden olur ve bu da kesilmi\u015f ancak i\u015flevsel bir distrofin proteininin ifadesine olanak tan\u0131r.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"mutations-amenable-to-exon-51-skipping\"><strong>Ekzon 53 Atlamaya Uygun Mutasyonlar<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Duchenne kas distrofisinde ekzon 53 atlamaya uygun mutasyonlar a\u015fa\u011f\u0131daki ekzonlar\u0131 i\u00e7erir<\/strong>: 3-52, 4-52, 5-52, 6-52, 9-52, 10-52, 11-52, 13-52, 14-52, 15-52, 16-52, 17-52, 19-52, 21-52, 23-52, 24-52, 25-52, 26-52 27-52, 28-52, 29-52, 30-52, 31-52, 32-52, 33-52, 34-52, 35-52, 36-52, 37-52, 38-52, 39-52, 40-52, 41-52, 42-52, 43-52, 45-52, 47-52, 48-52, 49-52, 50-52, 52, 54-58, 54-61, 54-63, 54-64, 54-66, 54-76, 54-77.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"golodirsen-a-leading-exon-53-skipping-drug\"><strong>Golodirsen: \u00d6nde Gelen Bir Ekzon 53 Atlama Tedavisi<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Golodirsen (Vyondys 53), ekzon 53 atlamay\u0131 destekleyen FDA onayl\u0131 bir antisens oligon\u00fckleotiddir (AON).<\/strong> Golodirsen, distrofin geninin RNA transkriptine ba\u011flanarak, ekleme mekanizmas\u0131n\u0131n RNA i\u015flenmesi s\u0131ras\u0131nda 53. ekzonu atlamas\u0131na neden olur ve b\u00f6ylece genin okuma \u00e7er\u00e7evesini etkili bir \u015fekilde geri y\u00fckler. Bu, i\u015flevsel ancak kesik bir distrofin proteininin \u00fcretilmesini sa\u011flar. <strong>(Ekzon 52 delesyonu olan DMD hastalar\u0131, ekzon 51 veya ekzon 53'\u00fc atlayan bir tedaviyle tedavi edilebilir.)<\/strong> \u2013 <a href=\"https:\/\/www.vyondys53.com\/\" data-type=\"link\" data-id=\"https:\/\/www.vyondys53.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Devam\u0131n\u0131 oku<\/a> \u2013 <\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"clinical-trials-and-results\"><strong>Klinik Ara\u015ft\u0131rmalar ve Sonu\u00e7lar\u0131<\/strong><\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Klinik \u00e7al\u0131\u015fmalarda, golodirsen kas biyopsilerinde distrofin seviyelerinde \u00f6nemli bir art\u0131\u015f g\u00f6stermi\u015ftir; bu da tedavinin etkinli\u011finin \u00f6nemli bir g\u00f6stergesidir. \u00dcretilen distrofin miktar\u0131, sa\u011fl\u0131kl\u0131 kas dokusunda bulunan tam uzunluktaki versiyondan daha az olsa da, kas liflerini daha fazla hasardan korumak ve hastal\u0131\u011f\u0131n ilerlemesini yava\u015flatmak i\u00e7in yeterlidir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Etkililik:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Klinik \u00e7al\u0131\u015fmalar golodirsenin ekzon 53 delesyonu olan hastalarda distrofin ekspresyonunu ba\u015far\u0131yla art\u0131rd\u0131\u011f\u0131n\u0131 g\u00f6stermi\u015ftir.<\/li>\n\n\n\n<li>Distrofin d\u00fczeyleri normal kas dokusundan d\u00fc\u015f\u00fck kalsa da \u00fcretilen miktar fonksiyonel bir ikame sa\u011flamaya yeterli olup, kas g\u00fc\u00e7s\u00fczl\u00fc\u011f\u00fcn\u00fcn \u015fiddetini azaltt\u0131.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>G\u00fcvenlik Profili:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Golodirsenin g\u00fcvenlik profili olumlu olup, enjeksiyon b\u00f6lgesi reaksiyonlar\u0131 ve solunum yolu enfeksiyonlar\u0131 gibi hafif ila orta \u015fiddette yan etkiler g\u00f6r\u00fclm\u00fc\u015ft\u00fcr. Bu yan etkiler, intraven\u00f6z inf\u00fczyon yoluyla uygulanan ila\u00e7larda yayg\u0131nd\u0131r.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"benefits-of-exon-53-skipping-therapy-for-dmd-patients\"><strong>DMD Hastalar\u0131 \u0130\u00e7in Ekzon 53 Atlama Terapisinin Faydalar\u0131<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Golodirsen gibi Ekzon 53 atlama terapileri DMD'li hastalar i\u00e7in bir\u00e7ok \u00f6nemli fayda sunmaktad\u0131r:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Hastal\u0131\u011f\u0131n \u0130lerlemesini Yava\u015flat\u0131r:<\/strong> Ekzon atlama, distrofin \u00fcretiminin bir k\u0131sm\u0131n\u0131 geri kazand\u0131rarak kas liflerinin dejenerasyonunu yava\u015flatabilir ve kas g\u00fcc\u00fcn\u00fcn ve fonksiyonunun korunmas\u0131na yard\u0131mc\u0131 olabilir.<\/li>\n\n\n\n<li><strong>Ya\u015fam Kalitesinde \u0130yile\u015fme:<\/strong> Kas fonksiyonlar\u0131n\u0131n iyile\u015fmesiyle birlikte bir\u00e7ok hasta daha az yorgunluk ve daha fazla hareket kabiliyeti ya\u015fayabilir, bu da onlar\u0131n daha uzun s\u00fcre ba\u011f\u0131ms\u0131zl\u0131klar\u0131n\u0131 korumalar\u0131na olanak tan\u0131r.<\/li>\n\n\n\n<li><strong>Belirli Mutasyonlara Y\u00f6nelik Hedefli Tedavi:<\/strong> Ekzon 53 atlama, ekzon 52 b\u00f6lgelerini \u00e7evreleyen delesyonlar\u0131 olan hastalar i\u00e7in olduk\u00e7a spesifiktir ve bu DMD hasta grubu i\u00e7in ki\u015fiye \u00f6zel bir tedavi yakla\u015f\u0131m\u0131 sa\u011flar.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"future-prospects-expanding-exon-skipping-therapies\"><strong>Gelecek Beklentileri: Ekzon Atlama Terapilerinin Geni\u015fletilmesi<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ekzon 53 atlamas\u0131, belirli mutasyonlara sahip hastalar i\u00e7in \u00f6nemli bir at\u0131l\u0131m\u0131 temsil etse de, ekzon atlaman\u0131n potansiyeli ekzon 53'\u00fcn \u00f6tesine uzanmaktad\u0131r. Ara\u015ft\u0131rmac\u0131lar, distrofin genindeki 51, 45 ve 44. ekzonlar da dahil olmak \u00fczere di\u011fer ekzonlar\u0131 hedef alan tedaviler \u00fczerinde \u00e7al\u0131\u015fmaktad\u0131r. Genetik testler ilerledik\u00e7e, daha ki\u015fiselle\u015ftirilmi\u015f tedaviler ortaya \u00e7\u0131kacak ve daha geni\u015f bir DMD hastas\u0131 yelpazesi i\u00e7in umut vaat edecektir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ekzon atlaman\u0131n CRISPR gibi gen d\u00fczenleme teknikleriyle e\u015fle\u015ftirilmesi gibi kombinasyon tedavileri, bu tedavilerin etkinli\u011fini daha da art\u0131rabilir. Ara\u015ft\u0131rmac\u0131lar, birden fazla yakla\u015f\u0131m\u0131 birlikte kullanarak distrofin fonksiyonunu tam veya tama yak\u0131n bir seviyeye getirmeyi ve hastalara daha uzun s\u00fcreli faydalar sa\u011flamay\u0131 umuyorlar. \u2013 Devam\u0131n\u0131 Oku: <a href=\"https:\/\/dmdwarrior.com\/tr\/crispr-cas13-could-accelerate-studies-on-rna-targeted-therapies\/\" target=\"_blank\" data-type=\"post\" data-id=\"1418\" rel=\"noreferrer noopener\">CRISPR<\/a> \u2013<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"summary-is-your-child-a-candidate-for-exon-51-skipping\"><strong>\u00d6zet: O\u011flum Ekzon 53 Atlamaya Uygun mu?<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">O\u011flunuza DMD te\u015fhisi konulduysa ve 52. ekzon yak\u0131n\u0131nda bir mutasyon varsa (\u00f6rne\u011fin 45 ila 52. ekzonlar\u0131n silinmesi), 53. ekzon atlama terapisinden faydalanma olas\u0131l\u0131\u011f\u0131 vard\u0131r.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\ud83d\udd0d \u00d6nemli Noktalar:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ekzon 53 atlanmas\u0131, belirli delesyonlarda distrofin okuma \u00e7er\u00e7evesinin geri kazan\u0131lmas\u0131na yard\u0131mc\u0131 olur.<\/li>\n\n\n\n<li>DMD hastalar\u0131n\u0131n yakla\u015f\u0131k %8&#039;i uygundur.<\/li>\n\n\n\n<li>Uygunlu\u011fun belirlenmesi i\u00e7in genetik test yap\u0131lmas\u0131 \u015fartt\u0131r.<\/li>\n\n\n\n<li>Golodirsen (Vyondys 53) gibi tedaviler, ekzon 53&#039;e uyumlu mutasyonlar i\u00e7in FDA taraf\u0131ndan onaylanm\u0131\u015ft\u0131r.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"conclusion\"><strong>Sonu\u00e7<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ekzon 53 atlama tedavileri, \u00f6zellikle ekzon 53'\u00fc etkileyen delesyonlar\u0131 olan hastalar i\u00e7in Duchenne Musk\u00fcler Distrofisi tedavisinde heyecan verici bir \u00e7\u0131\u011f\u0131r a\u00e7maktad\u0131r. Ekzon 53'\u00fc hedef alan ilk FDA onayl\u0131 ila\u00e7 olan Golodirsen, klinik \u00e7al\u0131\u015fmalarda umut vadeden sonu\u00e7lar vermi\u015f ve hastal\u0131\u011f\u0131n ilerlemesini yava\u015flatma ve ya\u015fam kalitesini iyile\u015ftirme konusunda umut vadetmektedir. Ara\u015ft\u0131rmalar devam ettik\u00e7e, ekzon atlama, DMD i\u00e7in daha geni\u015f kapsaml\u0131 bir tedavi stratejisinin ayr\u0131lmaz bir par\u00e7as\u0131 haline gelebilir ve bu y\u0131k\u0131c\u0131 durumdan etkilenen bireyler i\u00e7in daha ki\u015fiye \u00f6zel ve etkili tedaviler sunabilir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Genetik tedaviler ve ki\u015fiselle\u015ftirilmi\u015f t\u0131p alan\u0131ndaki geli\u015fmelerle birlikte Duchenne Musk\u00fcler Distrofisi ile ya\u015fayanlar\u0131n gelece\u011fi daha parlak g\u00f6r\u00fcn\u00fcyor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Devam\u0131n\u0131 oku<\/strong>:\u00a0<a href=\"https:\/\/dmdwarrior.com\/tr\/dmd-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">Duchenne \u0130\u00e7in Klinik Ara\u015ft\u0131rmalar (T\u00fcm Ara\u015ft\u0131rmalar\u0131n Listesi)<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Duchenne Muscular Dystrophy (DMD) is a debilitating and progressive genetic disorder that primarily affects boys, causing muscle weakness and degeneration due to mutations in the dystrophin gene. Over the years, therapeutic advancements have been made to halt the progression of DMD, with one of the most promising being exon skipping therapies. These therapies aim to [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4570,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[155,154,328,77,178],"class_list":["post-4559","post","type-post","status-publish","format-standard","has-post-thumbnail","category-dmd","tag-exon-53","tag-exon-53-skipping","tag-exon-53-skipping-therapy","tag-exon-skipping","tag-exon-skipping-therapies"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/4559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=4559"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/4559\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/4570"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=4559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=4559"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=4559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}